These medications work by delaying digestion, which can lead to symptoms like early fullness, nausea, and bloating
This necessitates exploration of novel therapeutic options to delay the onset of KF
In this study, we were only able to include medicated patients, as recruitment of drug-nave patients was not possible
Mechanism: Semaglutide targets only GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors, offering a dual effect
INTRODUCTION Melasma is an acquired, chronic, and recurrent form of hypermelanosis, which is characterized by symmetrical brown macules and patches of variable darkness on sun exposed areas of the body, typically occurring on the face (lower cheeks, forehead, nose, and upper lip).[] Though the pathogenesis of melasma is unclear, factors such as genetic makeup, ultraviolet (UV) radiation, pregnancy, and hormonal therapy are known to influence the development of melasma
Among these, online GLP-1 programs have gained popularity for their ability to integrate advanced medication like GLP-1 with modern convenience